Cardio-oncology & otherCohort study

Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study

Eur Heart JPublished

  • Prospective cohort study
  • multicentre
  • 34 centres in 16 countries

Authors' conclusion

COVID-19 is associated with early vascular ageing in the long term, especially in women.

Study context

Population
COVID-19 survivors and COVID-19-negative controls (age 50 ± 15 years, 49.2% women)
Participants
2,390 survivors
Exposure
COVID-19-positive vs COVID-19-negative controls
Outcome
Carotid-femoral pulse wave velocity (PWV), a biomarker of large artery stiffness

Main finding

As reported in the abstract

Adjusted PWV

Controls

7.53

adjusted mean · 95% CI 7.09–7.97 · m/s

Not hospitalized vs Controls
difference +0.41 m/s; P < 0.001
General wards vs Controls
difference +0.37 m/s; P = 0.001
ICU vs Controls
difference +0.40 m/s; P = 0.003

Observational data: associations, not effects.

Further findings

Adjusted pulse wave velocity (PWV) difference vs controls, women (sex-stratified)

m/s

Women, group 2 (not hospitalized) vs controls
+0.55
Women, group 3 (general wards) vs controls
+0.60
Women, group 4 (intensive care units) vs controls
+1.09
  • P < .001 for all

Adjusted PWV difference vs controls, men (sex-stratified)

PWV differences not significant in men

PWV by persistent symptoms, COVID-19-positive women

Persistent symptoms: adjusted PWV
7.52 m/s (95% CI 7.09; 7.96)
No persistent symptoms: adjusted PWV
7.13 m/s (95% CI 6.67; 7.59)
Persistent symptoms vs none
P < 0.001
  • regardless of disease severity and CV confounders

PWV change over 12 months

Stable or improved PWV in COVID+ groups; progression in COVID- group

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study. Eur Heart J. Published 17 August 2025. doi:10.1093/eurheartj/ehaf430

Summarised from the published abstract; every number is checked against it